Who is happy about the new home HD vs. PD survival study?
We bet that you can guess that NxStage is pretty excited about the terrific 5-year survival outcomes of home HD—especially since nocturnal HD (which is much more like the treatment done in Australia and New Zealand) has finally been approved in the US.
Read the full article » | Posted 07-08-2015
Related Articles
- Baxter Announces Multiple Online Training Videos for Professionals Posted 04-12-2024
- Humana and Strive Health Expand Holistic Partnership to more Humana Members Posted 04-12-2024
- ASN and Home Dialysis University Collaboration to Increase Home Dialysis Posted 04-12-2024
- Telemedicine Can Help Grow Home Dialysis, Reduce Dropout, and Improve Outcomes Posted 03-15-2024